July 20, 20204 yr ovo su detailji vezani za vest od prosle nedelje da "oxfordska" vakcina ide u trecu fazu istrazivanja.
July 20, 20204 yr Izbacio i Cansino rezultate: https://www.thelancet.com/lancet/article/s0140-6736(20)31605-6
July 20, 20204 yr On 19. 7. 2020. at 18:02, Frile said: sa burundija, pre dva dana: Pitala mikrobiologa, kaže da je subjunit teža za dobiti, bezbednija ( sadrži samo one delove virusa koji stimulišu imunski odgovor) i...skuplja. Verovatno tu treba tražiti razlog promene dobavljača, neko će lepo da se utali. Hajdi je, inače, epidemiolog, imala je još par ispada, pa joj ne bih puno verovala oko stvari koje nisu njena uža specijalnost.
July 21, 20204 yr Покушавам да нађем на нету чланак о „резаражавању“ (), јер сам с више страна чула „знам неког ко се заразио опет после 2 месеца“. Можда сви знају исту особу, а можда је у питању више њих. Међутим, ако је то случај, да можемо релативно брзо опет да добијемо ковид, то значи да ћемо ми са овим српским темпом да се заразимо три пута до вакцине, па ко преживи... Овде пише да вирус може да буде присутан у организму и више месеци. https://www.nature.com/articles/s41598-020-68782-w (што ми је чак и утешно) Quote Asymptomatic carriers can be re-positive We noticed the particular case of an 8-year-old boy (case 19) who had Hubei exposure history during Jan 10–16, 2020, who were re-tested positive for repeated times. He returned from a journey from Hubei to Shenzhen on Jan 26, 2020. His grandfather was confirmed to be infected with COVID-19 on Jan 31, 2020. Due to their close contact, throat swab tests were performed for the whole family and on Feb 1, 2020, the boy was confirmed as having COVID-19, and hospitalized. No fever or other symptoms were detected during his hospitalization. He reached the hospital discharge criteria (according to the 4th Trail edition) on Feb 15, but was requested to transfer to an isolation hotel for another 14 days (Feb 15–28) due to the positive results of an anal swab test on Feb 14. During hotel isolation, results on two test days (Feb 21 and 28) were negative, and thus he was allowed to go home. On his return hospital visit on Mar 2, an anal swab test showed a positive result, and he was hospitalized for a second time. During the second hospitalization, results on two test days (Mar 5 and 7) were negative, and he was transferred to isolation observation for a second period of 14 days from Mar 8. In the routine tests performed on Mar 15 (day seven of the second isolation observation), the anal swab test result revealed another positive result (Fig. 1B). Therefore he was hospitalized for a third time. During the third hospitalization, two further tests were performed, and there was a positive result (anal swab) on the 4th day at the designated hospital (Fig. 1A, case 19). It has been 35 days since his first recovery and discharge from hospital, and viral RNA remains, although there are no clinical symptoms.
July 21, 20204 yr https://www.blic.rs/vesti/drustvo/kaubojska-medicina-ne-daje-rezultate-srpski-naucnici-iz-amerike-objasnjavaju-koja-dva/vg4shsv
July 21, 20204 yr On 21. 7. 2020. at 7:43, Jumanji said: Juce je bila vest da i ruska vakcina daje imuni odgovor Ovo kao trka za osvajanje kosmosa, ko ce prvi da lansira coveka, dan razlike se racuna
July 21, 20204 yr https://zena.blic.rs/zdravlje/nova-istrazivanja-pokazala-su-da-lecenje-ovim-lekom-drasticno-smanjuje-tezinu/g2x1tvb “We are all delighted with the trial results announced today, which showed that SNG001 greatly reduced the number of hospitalised COVID-19 patients who progressed from ‘requiring oxygen’ to ‘requiring ventilation’. It also showed that patients who received SNG001 were at least twice as likely to recover to the point where their everyday activities were not compromised through having been infected by SARS-CoV-2. In addition, SNG001 has significantly reduced breathlessness, one of the main symptoms of severe COVID-19. This assessment of SNG001 in COVID-19 patients could signal a major breakthrough in the treatment of hospitalised COVID-19 patients. Our efforts are now focused on working with the regulators and other key groups to progress this potential COVID-19 treatment as rapidly as possible.” – Richard Marsden, CEO of Synairgen. Edited July 21, 20204 yr by slow
July 23, 20204 yr Evo malo objašnjenja oko ove nove terapije što je @slow kačio A evo i članak in nyt o "rezaražavanju" https://www.nytimes.com/2020/07/22/health/covid-antibodies-herd-immunity.html Edited July 23, 20204 yr by yabadaba
July 23, 20204 yr Oksfordska vakcina možda stigne u Srbiju, ali u licencnom izdanju preko Moskve. Quote Russian drugmaker R-Pharm has signed a licensing deal with Britain's AstraZeneca to produce and distribute doses of its University of Oxford-partnered adenovirus-based COVID-19 shot, AZD1222. As part of the agreement, R-Pharm will export Oxford's shot to markets in the Commonwealth of Independent States—a nine-country economic group including Russia and post-Soviet republics—the Middle East and the Balkans, an AstraZeneca spokesman said. The number of doses included in the deal has yet to be determined, AstraZeneca said. https://www.fiercepharma.com/pharma/astrazeneca-signs-covid-19-shot-deal-russia-days-after-hacking-accusations-surface
July 23, 20204 yr On 23. 7. 2020. at 7:49, yabadaba said: Evo malo objašnjenja oko ove nove terapije što je @slow kačio Jeste, a kada Kubanci jos marta meseca objave da koriste interferon kao terapiju, onda je to vlaska magija Kulturrasizam Edited July 23, 20204 yr by Caligula
July 24, 20204 yr On 19. 7. 2020. at 18:02, Frile said: sa burundija, pre dva dana: evo sad rekli da će uvozne vakcine biti četvorovalentne, a da će torlak praviti trovalentne